Earnings History Data for Talis Biomedical Corporation (TLIS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Talis Biomedical Corporation

Talis Biomedical Corporation engaged in developing and commercializing products for infectious diseases at the point-of-care. The company involved in developing the Talis One platform, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. Talis Biomedical Corporation is based in MENLO PARK, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
10-08-2023	AH		TLIS	Talis Biomedical Corporation	13.57	-8.27	0.00	-15.14	Talis Biomedical GAAP EPS of -$8.27 misses by $0.02, revenue of $0.58M beats by $0.47M [8/10/2023 5:46 PM]	7.51	-0.08 (-1.05%)	7.15	-0.44 (-5.80%)	6.32 - 18.00	2,257	10,000	126
Talis Biomedical GAAP EPS of -$8.27 misses by $0.02, revenue of $0.58M beats by $0.47M [8/10/2023 5:46 PM]
11-05-2023	AH	4:05 PM ET (May 11)	TLIS	Talis Biomedical Corporation	28.75	-0.66	-0.74	-1.25	Talis Biomedical reports Q1 results [5/11/2023 4:36 PM]	0.4786	-0.04 (-7.14%)	0.54	0.0 (0.20%)	0.42 - 1.20	200,845	50,000	1,106
Talis Biomedical reports Q1 results [5/11/2023 4:36 PM]
03-11-2022	AH	4:05 PM ET (Nov 3)	TLIS	Talis Biomedical	18.00	-0.98	-0.74	0.00	Talis Biomedical reports Q3 results [11/3/2022 5:27 PM]	0.6378	-0.05 (-7.57%)	0.0	0.0 (0.00%)	0.61 - 6.45	70,908	120,000	0
Talis Biomedical reports Q3 results [11/3/2022 5:27 PM] Talis Biomedical Reports Third Quarter 2022 Financial Results [Nov-03-22 04:05PM]
02-08-2022	AH	After the close (Aug 2)	TLIS	Talis Biomedical	21.00	-1.01	-0.82	0.00	Talis Biomedical reports Q2 results [8/2/2022 5:20 PM]	0.7750	0.01 (1.44%)	0.79	0.03 (3.40%)	0.76 - 10.59	90,743	70,000	15,720
Talis Biomedical reports Q2 results [8/2/2022 5:20 PM] Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results [Aug-02-22 04:05PM]
10-05-2022	AH	4:05 PM ET (May 10)	TLIS	Talis Biomedical Corporation	58.14	-1.25	-1.14	-4.61		1.09	-0.08 (-7.20%)	0.98	-0.20 (-16.95%)	0.96 - 12.88	549,424	170,000	24,193
Talis Biomedical Q1 revenue of $3.2M [5/10/2022 5:12 PM] Can Talis Biomedical (NASDAQ:TLIS) Afford To Invest In Growth? [May-10-22 11:08AM] Talis Biomedical Announces First Quarter 2022 Financial Results [May-10-22 04:05PM]
15-03-2022	AH	4:05 PM ET (Mar 15)	TLIS	Talis Biomedical	46.00	N/A	-1.20	0.00	Talis Biomedical net loss of $28.65M, revenue of $0.86M misses by $0.47M [3/15/2022 4:15 PM]	1.32	-0.37 (-21.90%)	1.62	-0.07 (-4.14%)	0.96 - 17.50	1,319,824	120,188	15,928
Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-15-22 04:05PM] Talis Biomedical Corporation (TLIS) Q4 2021 Earnings Call Transcript [Mar-15-22 09:30PM]
15-11-2021	AH	4:05 PM ET (Nov 15)	TLIS	Talis Biomedical Corporation	287.52	-1.49	-1.67	0.00	Talis Biomedical EPS beats by $0.18, beats on revenue [11/15/2021 4:14 PM]	4.78	-1.02 (-17.59%)	5.80	0.0 (0.00%)	4.74 - 33.90	434,128	230,000	320
Talis Biomedical EPS beats by $0.18, beats on revenue [11/15/2021 4:14 PM] Talis Biomedical appoints former Abbott executive as CEO [11/15/2021 4:59 PM] Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors [Nov-12-21 12:00PM] Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress [Nov-15-21 04:05PM] Talis Biomedical Announces Appointment of Brian Blaser as President, Chief Executive Officer and Director [Nov-15-21 04:02PM] Talis Biomedical Corporation (TLIS) Q3 2021 Earnings Call Transcript [Nov-16-21 06:00AM]
10-08-2021	AH	4:05 PM ET (Aug 10)	TLIS	Talis Biomedical Corporation	529.17	-2.51	-0.87	0.00		8.38	-0.59 (-6.58%)	7.73	-1.24 (-13.82%)	7.50 - 33.90	740,978	290,000	30,503
Talis Biomedical cut to neutral at J.P. Morgan citing delay in product launch [8/11/2021 3:13 PM] We're Keeping An Eye On Talis Biomedical's (NASDAQ:TLIS) Cash Burn Rate [Aug-10-21 08:25AM] Talis Biomedical Announces Second Quarter 2021 Financial Results and Business Progress [Aug-10-21 04:05PM] Talis Biomedical (TLIS) Q2 2021 Earnings Call Transcript [Aug-11-21 02:10PM]
11-05-2021	AH	After the close (May 11)	TLIS	Talis Biomedical Corporation	618.25	-4.61	-0.79	0.00	Talis Biomedical EPS of -$4.61 [5/11/2021 4:31 PM]	11.02	0.88 (8.68%)	10.18	0.04 (0.39%)	9.43 - 33.90	88,840	70,000	1,076
Talis Biomedical EPS of -$4.61 [5/11/2021 4:31 PM] Talis Biomedical Corp to Host Earnings Call [May-11-21 02:30PM] Talis Biomedical Announces First Quarter 2021 Financial Results and Business Progress [May-11-21 04:05PM] Have Insiders Been Buying Talis Biomedical Corporation (NASDAQ:TLIS) Shares? [May-12-21 08:00AM]